Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas (2006)

  • Authors:
  • USP affiliated authors: GIANNELLA NETO, DANIEL - FM ; FORTES, MARIA ANGELA HENRIQUES ZANELLA - FM ; CAVALEIRO, ANA MERCEDES DE SOUSA - FM ; BRONSTEIN, MARCELO DELANO - FM
  • USP Schools: FM; FM; FM; FM
  • DOI: 10.1007/s11102-006-9277-1
  • Subjects: ADENOMA (SECREÇÃO); FÍGADO (FISIOPATOLOGIA); HEPATOPATIAS (ENZIMOLOGIA)
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: Pituitary
    • ISSN: 1386-341X
    • Volume/Número/Paginação/Ano: v. 9, p. 83-92, 2006
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s11102-006-9277-1 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Pituitary

    ISSN: 1386-341X

    Citescore - 2017: 2.5

    SJR - 2017: 0.876

    SNIP - 2017: 1.047


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM10700093061-SFM BCSEP 123 2006
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ROCHA, Anderson Alves da; GIORGI, Ricardo Rodrigues; SÁ, Sandra Valeria de; et al. Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas. Pituitary, Norwell, MA, v. 9, p. 83-92, 2006. DOI: 10.1007/s11102-006-9277-1.
    • APA

      Rocha, A. A. da, Giorgi, R. R., Sá, S. V. de, Cavaleiro, A. M., Correa-Giannella, M. L., Fortes, M. A. H. Z., et al. (2006). Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas. Pituitary, 9, 83-92. doi:10.1007/s11102-006-9277-1
    • NLM

      Rocha AA da, Giorgi RR, Sá SV de, Cavaleiro AM, Correa-Giannella ML, Fortes MAHZ, Cavaleiro AM, Machado MC, Cescato VA, Bronstein MD, Giannella Neto D. Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas. Pituitary. 2006 ; 9 83-92.
    • Vancouver

      Rocha AA da, Giorgi RR, Sá SV de, Cavaleiro AM, Correa-Giannella ML, Fortes MAHZ, Cavaleiro AM, Machado MC, Cescato VA, Bronstein MD, Giannella Neto D. Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas. Pituitary. 2006 ; 9 83-92.

    Referências citadas na obra
    Greenman Y, Melmed S (1996) Diagnosis and management of nonfunctioning pituitary tumors. Annu Rev Med 47:95–106
    Costello RT (1936) Subclinical adenoma of the pituitary gland. Am J Pathol 12:205–214
    Asa S, Ezzat S (1998) The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19:798–827
    Heaney AP, Melmed S (2000) New pituitary oncogenes. Endocr Relat Cancer 7:3–15
    Herman V, Drazin NZ, Gonsky R, Melmed S (1993) Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab 77:50–55
    Levy A, Hall L, Yedall WA, Lightman SL (1994) P53 gene mutations in pituitary adenomas: rare events. Clin Endocrinol (Oxf) 41:809–814
    Buckley N, Bates AS, Broome JC, Strange RC, Perret CW, Burke CW, Clayton RN (1994) p53 protein accumulation in Cushing’s adenoma and invasive nonfunctional adenomas. J Clin Endocrinol Metab 79:1513–1516
    Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER (1996) p53 expression in pituitary adenomas and carcinomas. Correlation with invasiveness and tumor growth fraction. Neurosurgery 38:765–771
    Zhang X, Horwitz GA, Heaney AP, Nakasaki M, Prezant TR, Bronstein MD, Melmed S (1999) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84:761–767
    Zhang X, Horwitz GA, Prezant TR, Valentini A, Nakashima M, Bronstein MD, Melmed S (1999) Struture, expression, and fuction of human pituitary tumor-transforming gene(PTTG). Mol Endocrinol 13:156–166
    Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S (1999) Early involvement of estrogen-induced pituitary tumour transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5:1317–1321
    Wang Z, Melmed S (2000) Pituitary tumor transforming gene (PTTG). Transforming and transativating activity. J Biol Chem 275:7459–7461
    McAndrew J, Paterson AJ, Asa SL, McCarthy KJ, Kudlow JE (1995) Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136:4479–4488
    Oomizu S, Honda J, Takeuchi S, Kadeya T, Masui T, Takahashi S (2000) Transforming growth factor-alpha stimulates proliferation of mamotrophs and corticotrophs in the mouse pituitary. J Endocrinol 165:493–501
    Ezzat S, Walpola IA, Ramyar L, Smyth HS, Asa SL (1995) Membrane anchored expression of transforming growth factor-alpha in human pituitary adenomas cells. J Clin Endocrinol Metab 80:534–539
    LeRiche VK, Asa SL, Ezzat S (1996) Epidermal growth factor and its receptor (EGF-R) in pituitary adenomas: EGF-R correlates with tumor agressiveness. J Clin Endocrinol Metab 81:656–662
    Evans CO, Young AN, Brown MR, Brat DJ, Parks JS, Neish AS, Oyesiku NM (2001) Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 86:3097–3107
    Morris DG, Musat M, Czirjak S, Hanzely Z, Lillington DM, Korbonits M, Grossman AB (2005) Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol 153:143–151
    Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM (2005) Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 65:10214–10222
    Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR (2003) MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profi le from microarray data. Genome Biol 4:R7
    Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR (2002) GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31:19–20
    Chen H, Huang XN, Stewart AF, Sepulveda JL (2004) Gene expression changes associated with fibronectin-induced cardiac myocyte hypertrophy. Physiol Genomics 18:273–283
    Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
    Dozmorov I, Knowlton N, Tang Y, Shields A, Pathipvanich P, Jarvis JN, Centola M (2004) Hypervariable genes—experimental error or hidden dynamics. Nucleic Acids Res 32:e147
    Komada M, Kitamura N (1995) Growth factor-induced tyrosine phosphorylation of Hrs, a novel 115-kilodalton protein with a structurally conserved putative zinc finger domain. Mol Cell Biol 15:6213–6221
    Urbe S, Mills IG, Stenmark H, Kitamura N, Clague MJ (2000) Endosomal localization and receptor dynamics determine tyrosine phosphorylation of hepatocyte growth factor-regulated tyrosine kinase substrate. Mol Cell Biol 20:7685–7692
    Komada M, Kitamura N (2001) Hrs and hbp: Possible regulators of endocytosis and exocytosis. Biochem Biophys Res Commun 281:1065–1069
    Morino C, Kato M, Yamamoto A, Mizuno E, Hayakawa A, Komada M, Kitamura N (2004) A role for Hrs in endosomal sorting of ligand-stimulated and unstimulated epidermal growth factor receptor. Exp Cell Res 297:380–391
    Lloyd TE, Atkinson R, Wu MN, Zhou Y, Pennetta G, Bellen HJ (2002) Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila. Cell 108:261–269
    Scoles DR, Qina Y, Nguyena V, Gutmannc DH, Pulsta SM (2005) HRS inhibits EGF receptor signaling in the RT4 rat schwannoma cell line. Biochem Biophys Res Commun 335:385–392
    Scoles DR, Huynh DP, Chen MS, Burke SP, Gutmann DH, Pulst SM (2000) The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate. Hum Mol Genet 9:1567–1574
    Sun CX, Haipek C, Scoles DR, Pulst SM, Giovannini M, Komada M, Gutmann DH (2002) Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate. Hum Mol Genet 11:3167–3178
    Gaidarov IO, Suslov ON, Abdulaev NG (1993) Enzymes of the cyclic GMP metabolism in bovine retina. I. Cloning and expression of the gene for guanylate kinase. FEBS Lett 335:81–84
    Bourne HR, Sanders DA, McCormick F (1990) The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348:125–132
    Huang H, Colella S, Kurrer M, Yonekawa Y, Kleihues P, Ohgaki H (2000) Gene Expression Profiling of Low-Grade Diffuse Astrocytomas by cDNA Arrays. Cancer Res 60:6868–6874
    Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717–797
    Muller EE, Locatelli V, Cocchi D (1999) Neuroendocrine control of growth hormone secretion. Physiol Rev 79:511–607
    Luque RM, Rodriguez-Pacheco F, Tena-Sempere M, Gracia-Navarro F, Malagon MM, Castano JP (2005) Differential Contribution of Nitric Oxide and cGMP to the Stimulatory Effects of Growth Hormone-Releasing Hormone and Low-Concentration Somatostatin on Growth Hormone Release from Somatotrophs. J Neuroendocrinol 17:577–582
    Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA (2000) Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52:375–414
    Kostic TS, Andric SA, Stojilkovic SS (2001) Spontaneous and receptor controlled soluble guanylyl cyclase activity in anterior pituitary cells. Mol Endocrinol 15:1010–1022